144 related articles for article (PubMed ID: 10630363)
1. Irinotecan in cancers of the lung and cervix.
Sandler A; van Oosterom AT
Anticancer Drugs; 1999 Nov; 10 Suppl 1():S13-7. PubMed ID: 10630363
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan in small-cell lung cancer--Japanese trials.
Fukuoka M; Masuda N; Kudoh S; Negoro S
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):57-62. PubMed ID: 10981292
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer.
Adjei AA; Argiris A; Murren JR
Semin Oncol; 1999 Oct; 26(5 Suppl 16):32-40; discussion 41-2. PubMed ID: 10585007
[TBL] [Abstract][Full Text] [Related]
4. The emerging world role of irinotecan in lung cancer.
Langer CJ
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):15-21. PubMed ID: 11497227
[TBL] [Abstract][Full Text] [Related]
5. Current role of irinotecan in the treatment of non-small-cell lung cancer.
Kelly K
Oncology (Williston Park); 2002 Sep; 16(9):1153-62, 1165; discussion 1165-6 passim. PubMed ID: 12380945
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan in advanced lung cancer: focus on North American trials.
Langer CJ
Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):17-28. PubMed ID: 15255164
[TBL] [Abstract][Full Text] [Related]
7. Clinical studies of irinotecan alone and in combination with cisplatin.
Fukuoka M; Masuda N
Cancer Chemother Pharmacol; 1994; 34 Suppl():S105-11. PubMed ID: 8070018
[TBL] [Abstract][Full Text] [Related]
8. Irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer.
Devore R; Johnson D; Crawford J; Dimery I; Eckardt J; Eckhardt SG
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):79-83. PubMed ID: 9726097
[TBL] [Abstract][Full Text] [Related]
9. Irinotecan in the treatment of small cell lung cancer: a review of patient safety considerations.
Kawahara M
Expert Opin Drug Saf; 2006 Mar; 5(2):303-12. PubMed ID: 16503750
[TBL] [Abstract][Full Text] [Related]
10. Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG).
Kentepozidis N; Economopoulou P; Christofyllakis C; Chelis L; Polyzos A; Vardakis N; Koinis F; Vamvakas L; Katsaounis P; Kalbakis K; Nikolaou C; Georgoulias V; Kotsakis A
Clin Transl Oncol; 2017 Mar; 19(3):317-325. PubMed ID: 27492015
[TBL] [Abstract][Full Text] [Related]
11. Establishment of the standard regimen for non-small-cell lung cancer in Japan.
Masuda N
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):13-8. PubMed ID: 11221016
[TBL] [Abstract][Full Text] [Related]
12. [Irinotecan].
Yokoyama A
Nihon Rinsho; 2002 May; 60 Suppl 5():339-42. PubMed ID: 12101684
[No Abstract] [Full Text] [Related]
13. Irinotecan therapy for small-cell lung cancer.
Sandler A
Oncology (Williston Park); 2002 Apr; 16(4):419-25, 428, 433; discussion 433-4, 437-8. PubMed ID: 12017533
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase I inhibitors in small-cell lung cancer. The Japanese experience.
Saijo N; Horiike A
Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):11-6. PubMed ID: 15255163
[TBL] [Abstract][Full Text] [Related]
15. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
[TBL] [Abstract][Full Text] [Related]
16. Role of topoisomerase I inhibitors in small-cell lung cancer.
Fukuoka M
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan for the treatment of cervical cancer.
Verschraegen CF
Oncology (Williston Park); 2002 May; 16(5 Suppl 5):32-4. PubMed ID: 12109804
[TBL] [Abstract][Full Text] [Related]
18. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A
Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091
[TBL] [Abstract][Full Text] [Related]
19. New directions for chemotherapy in non-small-cell lung cancer.
Green MR
Chest; 1993 Apr; 103(4 Suppl):370S-372S. PubMed ID: 8096453
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan in cervical cancer.
Kavanagh JJ; Verschraegen CF; Kudelka AP
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):94-8. PubMed ID: 9726099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
